|483.80||-16.55||-3.31%||Vol 1.73M||1Y Perf -8.42%|
|Dec 6th, 2023 16:00 DELAYED|
|- -||2.10 0.43%|
|Target Price||602.61||Analyst Rating||Strong Buy 1.50|
|Potential %||24.56||Finscreener Ranking||★★+ 48.17|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 45.81|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 57.85|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★+ 35.06|
|Price Range Ratio 52W %||46.40||Earnings Rating||Strong Sell|
|Market Cap||59.56B||Earnings Date||1st Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||7.15|
|EPS Growth Next 5 Years %||13.40|
|Avg. Weekly Volume||2.71M|
|Avg. Monthly Volume||1.38M|
|Avg. Quarterly Volume||1.12M|
Humana Inc. (NYSE: HUM) stock closed at 500.35 per share at the end of the most recent trading day (a 1.7% change compared to the prior day closing price) with a volume of 1.19M shares and market capitalization of 59.56B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 48700 people. Humana Inc. CEO is Bruce D. Broussard.
The one-year performance of Humana Inc. stock is -8.42%, while year-to-date (YTD) performance is -2.31%. HUM stock has a five-year performance of 58.2%. Its 52-week range is between 423.29 and 553.69, which gives HUM stock a 52-week price range ratio of 46.40%
Humana Inc. currently has a PE ratio of 22.30, a price-to-book (PB) ratio of 3.84, a price-to-sale (PS) ratio of 0.87, a price to cashflow ratio of 6.50, a PEG ratio of 1.66, a ROA of 6.30%, a ROC of -% and a ROE of 18.70%. The company’s profit margin is 4.00%, its EBITDA margin is -%, and its revenue ttm is $70.43 Billion , which makes it $556.33 revenue per share.
Of the last four earnings reports from Humana Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $7.15 for the next earnings report. Humana Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Humana Inc. is Strong Buy (1.5), with a target price of $602.61, which is +24.56% compared to the current price. The earnings rating for Humana Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Humana Inc. has a dividend yield of 0.65% with a dividend per share of $3.15 and a payout ratio of 9.00%.
Humana Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.65, ATR14 : 14.20, CCI20 : -25.09, Chaikin Money Flow : -0.06, MACD : -1.41, Money Flow Index : 34.49, ROC : -2.45, RSI : 50.07, STOCH (14,3) : 45.35, STOCH RSI : 0.72, UO : 36.22, Williams %R : -54.65), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Humana Inc. in the last 12-months were: Agrawal Vishal (Option Excercise at a value of $0), Bruce D. Broussard (Option Excercise at a value of $0), Bruce D. Broussard (Sold 42 150 shares of value $21 503 985 ), David A. Jones (Sold 15 000 shares of value $7 525 800 ), David T. Feinberg (Option Excercise at a value of $0), Deshpande Samir (Option Excercise at a value of $0), Diamond Susan (Option Excercise at a value of $1 220 748), Diamond Susan (Sold 4 156 shares of value $2 187 234 ), Diamond Susan M (Option Exercise at a value of $0), Felter John-Paul W. (Option Exercise at a value of $0), Fleming William (Option Excercise at a value of $0), George II Renaudin (Option Excercise at a value of $0), Joseph C. Ventura (Option Excercise at a value of $0), Joseph C. Ventura (Sold 2 048 shares of value $1 040 328 ), Samir Deshpande (Option Excercise at a value of $0), Schick Susan (Option Excercise at a value of $0), Smith Brad (Option Excercise at a value of $0), Susan D. Schick (Option Excercise at a value of $0), Susan M. Diamond (Option Excercise at a value of $0), Timothy Alan Wheatley (Option Excercise at a value of $0), Timothy S. Huval (Option Excercise at a value of $0), Timothy S. Huval (Sold 3 263 shares of value $1 657 124 ), Ventura Joseph (Option Excercise at a value of $0), Ventura Joseph (Sold 2 048 shares of value $1 040 322 ), Vishal Agrawal (Option Excercise at a value of $0), William Kevin Fleming (Option Excercise at a value of $0)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.